Chemokines such as CCL2, CCL5, and CXCL12 are known to recruit myeloid‐derived suppressor cells (MDSCs) to the tumor microenvironment, where they suppress T‐cell responses and promote tumor growth [70]. Here, CCL2 is linked to neoplasm.